natgillin/translations-raw huggingface dataset:
Pack sizes of 14, 28, 30, 42, 50, 56, 98, 100, 112, and multipacks containing 840 (20 x 42), 980 (10 x 98) or 1000 (20 x 50) tablets are presented.
Postoje veličine pakiranja od 14, 28, 30, 42, 50, 56, 98, 100, 112, višestruko pakiranje od 840 (20 x 42), 980 (10 x 98) ili 1000 (20 x 50) tableta.
No cytochrome P 450 catalysed metabolism has been detected in vitro.
In vitro nije otkriven metabolizam kataliziran citokromom P 450.
Memantine Merz should be administered once a day and should be taken at the same time every day.
Merz se mora primjenjivati jednom dnevno i potrebno ju je uzimati svaki dan u isto vrijeme.
The dosing pump is only screwed on once when starting the use, and should never be unscrewed.
Pumpicu za doziranje treba pričvrstiti zavrtanjem jednom na početku uporabe te je više ne bi trebalo odvrtati.
The other ingredients for Memantine Merz 5/10/15 and 20 mg film-coated tablets are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171) and additional for Memantine Merz 10 mg film-coated tablets is iron oxide yellow (E172) and for Memantine Merz 15 mg and Memantine Merz 20 mg film-coated tablets are iron oxide yellow and red (E 172), all in the tablet coating.
Drugi sastojci Memantine Merz 5/ 10/ 15 i 20 mg filmom obloženih tableta su mikrokristalična celuloza, umrežena karmelozanatrij, koloidni bezvodni silicijev dioksid i magnezijev stearat sve u jezgri tablete; te hipromeloza, makrogol 400, titanijev dioksid (E171) i dodatno za Memantine Merz 10 mg filmom obložene tablete žuti željezov oksid (E172), a za Memantine Merz 15 mg i Memantine Merz 20 mg filmom obložene tablete žuti i crveni željezov oksid (E172), sve u ovojnici tablete.
No data on the use of memantine in patients with severe hepatic impairment are available.
Nisu dostupni podaci o primjeni memantina kod bolesnika s teškim oštećenjem jetrene funkcije.
EU/1/12/799/018 840 film-coated tablets (20 packs of 42) EU/1/12/799/024 840 film-coated tablets (20 packs of 42)
EU/1/12/799/018 840 filmom obloženih tableta (20 pakiranja po 42) EU/1/12/799/024 840 filmom obloženih tableta (20 pakiranja po 42)
14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 42 film-coated tablets 50 film-coated tablets 56 film-coated tablets 98 film-coated tablets 100 film-coated tablets 112 film-coated tablets
14 filmom obloženih tableta 28 filmom obloženih tableta 30 filmom obloženih tableta 42 filmom obložene tablete 50 filmom obloženih tableta 56 filmom obloženih tableta 98 filmom obloženih tableta 100 filmom obloženih tableta 112 filmom obloženih tableta
Memantine Merz is used for the treatment of patients with moderate to severe Alzheimer's disease.
Merz se koristi za liječenje bolesnika s umjerenom do teškom Alzheimerovom bolešću.
The following Adverse Reactions listed in the Table below have been accumulated in clinical studies with Memantine Merz and since its introduction in the market.
U sljedećoj tablici prikazane su nuspojave prikupljene tijekom kliničkih ispitivanja s Memantine Merzom i nakon stavljanja lijeka u promet.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR 28 TABLETS - TREATMENT INITIATION PACK - 4 WEEK TREATMENT SCHEDULE
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA 28 TABLETA - PAKIRANJE ZA POČETAK
For memantine, no clinical data on exposed pregnancies are available.
Nema kliničkih podataka o izloženosti memantinu u trudnoći.
When patients were identified with concurrent worsening in all three domains, results showed a statistically significant effect of memantine in preventing worsening, as twice as many placebo-treated patients as memantine-treated patients showed worsening in all three domains (21% vs. 11%, p<0.0001).
U skupini bolesnika liječenih placebom bilo je dvostruko više pogoršanja u sva tri područja nego u skupini bolesnika liječenih memantinom (21% naspram 11%, p<0,0001).
The dosing pump head has two positions and is easy to turn - anticlockwise (unlocked position) and clockwise (locked position).
Uporaba pumpice za doziranje za raspršivanje: Vrh pumpice za doziranje ima dva položaja i lako ga je okrenuti - u smjeru suprotnom od kazaljke na satu (otključani položaj) i u smjeru kazaljke na satu (zaključani položaj).
In these situations the treatment should be carefully supervised, and the clinical benefit of Memantine Merz reassessed by your doctor on a regular basis.
U tim slučajevima liječenje mora biti pažljivo nadzirano, a liječnik treba redovito ponovno procjenjivati kliničku korist od uzimanja Memantine Merz.
Concomitant use of N-methyl-D-aspartate(NMDA)-antagonists such as amantadine, ketamine or dextromethorphan should be avoided.
Treba izbjegavati istodobnu primjenu antagonista N-metil-D-aspartata (NMDA) kao što su amantadin, ketamin ili dekstrometorfan.
In order to reduce the risk of undesirable effects the maintenance dose is achieved by upward titration of 5 mg per week over the first 3 weeks as follows.
Radi smanjenja rizika od nuspojava, doza održavanja se postiže povećavanjem doze od 5 mg tjedno tijekom prva 3 tjedna na sljedeći način.
In order to reduce the risk of undesirable effects the maintenance dose is achieved by upward titration of 5 mg per week over the first 3 weeks as follows:
Radi smanjenja rizika od nuspojava, doza održavanja se postiže povećavanjem doze od 5 mg tjedno tijekom prva 3 tjedna na sljedeći način:
Standard clinical procedures to remove active substance material, e.g. gastric lavage, carbo medicinalis (interruption of potential entero-hepatic recirculation), acidification of urine, forced diuresis should be used as appropriate.
Treba koristiti standardne kliničke postupke za uklanjanje djelatne tvari, npr. ispiranje želuca, primjenu medicinskog ugljena (prekidanje potencijalne enterohepatičke recirkulacije),
Concomitant use of other N-methyl-D-aspartate (NMDA)-antagonists such as amantadine, ketamine or dextromethorphan should be avoided.
Treba izbjegavati istodobnu primjenu drugih antagonista N-metil-D-aspartata (NMDA) kao što su amantadin, ketamin ili dekstrometorfan.
14 film-coated tablets 28 film-coated tablets 42 film-coated tablets 56 film-coated tablets 98 film-coated tablets
14 filmom obloženih tableta 28 filmom obloženih tableta 42 filmom obložene tablete 56 filmom obloženih tableta 98 filmom obloženih tableta
Memantine Merz contains the active substance memantine hydrochloride.
Memantine Merz sadrži djelatnu tvar memantinklorid.
H. Abbe Pharma GmbH Tel.: +370 52 711710
Abbe Pharma GmbH Tel.: +370 52 711710
In volunteers with normal kidney function, total clearance (Cltot) amounts to 170 ml/min/1.73 m² and part of total renal clearance is achieved by tubular secretion.
Kod dobrovoljaca s normalnom funkcijom bubrega, ukupni klirens (Cltot) iznosi do 170 ml/min/1,73 m², a dio ukupnog bubrežnog klirensa postiže se tubularnom sekrecijom.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR 42, 50 AND 98 TABLETS AS INTERMEDIATE PACK / COMPONENT OF A MULTIPACK (WITHOUT BLUE BOX)
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA 42, 50 I 98 TABLETA KAO SREDNJE PAKIRANJE / DIO VIŠESTRUKOG PAKIRANJA (BEZ PLAVOG OKVIRA)
Main human metabolites are N-3,5-dimethyl-gludantan, the isomeric mixture of 4- and 6-hydroxy-memantine, and 1-nitroso-3,5-dimethyl-adamantane.
Glavni metaboliti kod ljudi su N-3,5-dimetil-gludantan, izomerna mješavina 4- i 6-hidroksi-memantina i 1-nitrozo-3,5dimetil-adamantan.
The recommended dose of Memantine Merz for adults and older people is four pump actuations, equivalent to 20 mg once a day.
Preporučena doza Memantine Merza za odrasle i starije osobe je četiri potiska pumpice, što odgovara 20 mg jednom dnevno.
In single-dose pharmacokinetic (PK) studies in young healthy subjects no relevant active substance-active substance interaction of memantine with glyburide/metformin or donepezil was observed.
U farmakokinetičkim ispitivanjima (PK) u kojima su primijenjene pojedinačne doze kod mladih zdravih ispitanika nije uočena značajna interakcija djelatna tvar-djelatna tvar memantina s gliburidom/metforminom ili donepezilom.
H. Abbe Pharma GmbH Tel.: +372 6 460980
Abbe Pharma GmbH Tel.: +372 6 460980
PARTICULARS TO APPEAR ON THE OUTER PACKAGING INNER CARTON FOR BLISTER PACK; frontside
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU UNUTARNJA KUTIJA ZA BLISTER; prednja strana
The usual starting dose is half a tablet once a day (1x 5 mg) for the first week.
Uobičajena početna doza iznosi pola tablete jedanput na dan (1 x 5 mg) tijekom prvog tjedna.
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg tablets
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg tablete
In order to reduce the risk of side effects this dose is achieved gradually by the following daily treatment scheme:
Kako bi se smanjio rizik od nuspojava, ta doza se postiže postupno pridržavajući se sljedeće sheme dnevnog liječenja:
In this case, monitoring of your kidney function should be performed by your doctor at specified intervals.
U tom slučaju, liječnik treba u određenim razmacima nadzirati funkciju bubrega.
In single-dose pharmacokinetic (PK) studies in young healthy subjects no relevant active substanceactive substance interaction of memantine with glyburide/metformin or donepezil was observed.
U farmakokinetičkim ispitivanjima (PK) u kojima su primijenjene pojedinačne doze kod mladih zdravih ispitanika nije uočena značajna interakcija djelatna tvar-djelatna tvar između memantina i gliburida/metformina ili donepezila.
EXP {MM/YYYY} See embossed stamp.
Rok valjanosti {MM/GGGG} Vidjeti reljefni otisak.
What is Memantine Merz used for
Za što se Memantine Merz koristi
In clinical trials in mild to severe dementia, involving 1,784 patients treated with Memantine Merz and 1,595 patients treated with placebo, the overall incidence rate of adverse reactions with Memantine Merz did not differ from those with placebo; the adverse reactions were usually mild to moderate in severity.
Merzom, a 1595 ih je dobivalo placebo sveukupna stopa incidencije nuspojava u skupini liječenoj Memantine Merzom nije se razlikovala od stope incidencije nuspojava u skupini koja je primala placebo.
The usual starting dose is one pump actuation (1 x 5 mg) once daily for the first week.
Uobičajena početna doza je jedan potisak pumpice jednom dnevno (1 x 5 mg) tijekom prvog tjedna.
H. Abbe Pharma GmbH Tel.: +371 67 103203
Abbe Pharma GmbH Tel.: +371 67 103203
The recommended daily dose is 20 mg once a day.
Preporučena dnevna doza je 20 mg jedanput na dan.
The Memantine Merz treatment initiation pack is only to be used for the beginning of the treatment with Memantine Merz.
Pakovanje ovaj lijek za početak liječenja se treba koristiti samo na početku liječenja Memantine
Do not store above 30ºC.
POSEBNE MJERE ČUVANJA Ne čuvati na temperaturi iznad 30ºC.
Memantine Merz film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 42 tablets, 56 tablets, 98 tablets or in multipacks of 840 (20 x 42) tablets.
Memantine Merz filmom obložene tablete su dostupne u pakiranjima s blisterima od 14 tableta, 28 tableta, 42 tablete, 56 tableta, 98 tableta i višestrukim pakiranjima od 840 (20 pakiranja od 42) tableta.
Memantine Merz should be taken once daily at the same time each day.
Merz se mora uzimati jednom dnevno, svaki dan u isto vrijeme.
Balance disorder
Često poremećaj ravnoteže
How to take Memantine Merz
KAKO UZIMATI MEMANTINE MERZ
No adverse effects of memantine were noted on non-clinical male and female fertility studies.
Štetni učinci memantina u nekliničkim ispitivanjima plodnosti kod mužjaka i ženki nisu zabilježeni.
Venous thrombosis/thromboembolism
Manje često venska tromboza/tromboembolija
At a dose of memantine of 20 mg per day the CSF levels match the ki-value (ki = inhibition constant) of memantine, which is 0.5 µmol in human frontal cortex.
Pri dozi od 20 mg memantina dnevno, razine u CSL-u odgovaraju ki-vrijednosti (ki = konstanta inhibicije) memantina koja u frontalnom korteksu kod ljudi iznosi 0,5 µmol.
One pump actuation contains 5mg memantine hydrochloride.
Jedan potisak pumpice sadrži 5 mg memantinklorida.
For removing the screw cap from the bottle the cap must be turned anticlockwise and unscrewed completely (fig.1).
Za uklanjanje zatvarača s navojem s boce, zatvarač se mora okrenuti u smjeru suprotnom od kazaljke na satu i potpuno odvrnuti (sl.1).
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR BLISTER PACK
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA BLISTER
In patients with mildly impaired renal function (creatinine clearance 50 - 80 ml/min) no dose adjustment is required.
Kod bolesnika s blagim oštećenjem funkcije bubrežne funkcije (klirens kreatinina 50-80 ml/min) nije potrebna prilagodba doze.
Week 2 (day 8-14): Take one 10 mg tablet once a day (pale yellow to yellow, oval shaped) for 7 days.
2. tjedan (8. - 14. dan): Uzimajte jednu tabletu od 10 mg jednom dnevno (blijedožutu do žutu, ovalnog oblika) tijekom 7 dana.
Discontinuation of memantine should be considered when evidence of a therapeutic effect is no longer present or if the patient does not tolerate treatment.
Kada više ne postoji dokaz terapijskog učinka ili ako bolesnik ne podnosi liječenje, treba razmotriti prekid liječenja memantinom.
Administration of Memantine Merz in patients with severe hepatic impairment is not recommended.
Ne preporučuje se primjena Memantine Merza kod bolesnika s teškim oštećenjem jetrene funkcije.
Memantine Merz film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 30 tablets, 42 tablets, 50 tablets, 56 tablets, 98 tablets, 100 tablets, 112 tablets and multipscks of 840 (20 packs of 42) tablets, 980 (10 packs of 98) tablets or 1000 (20 packs of 50) tablets.
Memantine Merz filmom obložene tablete dostupne su u pakiranjima s blisterima od 14 tableta, 28 tableta, 30 tableta, 42 tablete, 50 tableta, 56 tableta, 98 tableta, 100 tableta, 112 tableta; i višestrukim pakiranjima od 840 (20 pakiranja od 42) tableta, 980 (10 pakiranja od 98) tableta ili 1000 (20 pakiranja od 50) tableta.
The recommended dose of Memantine Merz for adults and older people is 20 mg once a day.
Preporučena doza Memantine Merza za odrasle i starije osobe je 20 mg jednom dnevno.
Women taking memantine should not breast-feed.
Žene koje uzimaju memantin ne bi trebale dojiti.
In order to reduce the risk of side effects this dose is achieved gradually by the following daily treatment scheme.
Kako bi se smanjio rizik od nuspojava, ta doza se postiže postupno, pridržavajući se sheme dnevnog liječenja.
Women taking Memantine Merz should not breast-feed.
Žene koje uzimaju Memantine Merz ne smiju dojiti.
Potassium sorbate Sorbitol E 420
6.1 Popis pomoćnih tvari kalijev sorbat sorbitol E420
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet) or if you are suffering from states of renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine),as your doctor may need to adjust the dose of your medicine.
Ako ste nedavno promijenili, ili namjeravate značajno promijeniti svoj način prehrane (npr. s normalne prehrane na strogu vegetarijansku prehranu), ili ako bolujete od stanja renalne tubularne acidoze (RTA - izrazito povećana količina tvari koje tvore kiseline u krvi zbog poremećaja rada bubrega (slaba funkcija bubrega)) ili teških infekcija mokraćnog trakta (struktura kroz koje prolazi mokraća), trebali bi obavijestiti svog liječnika jer će Vam liječnik možda morati prilagoditi dozu lijeka.
From Week 4 on: The patient should take two 10 mg film-coated tablets (20 mg) per day.
Od 4. tjedna nadalje: Bolesnik treba uzimati dvije filmom obložene tablete od 10 mg (20 mg) dnevno.
- amantadine, ketamine, dextromethorphan - dantrolene, baclofen - cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine - hydrochlorothiazide (or any combination with hydrochlorothiazide) - anticholinergics (substances generally used to treat movement disorders or intestinal cramps) - anticonvulsants (substances used to prevent and relieve seizures) - barbiturates (substances generally used to induce sleep) - dopaminergic agonists (substances such as L-dopa, bromocriptine) - neuroleptics (substances used in the treatment of mental disorders) - oral anticoagulants
- amantadina, ketamina, dekstrometorfana - dantrolena, baklofena - cimetidina, ranitidina, prokainamida, kinidina, kinina, nikotina - hidroklorotiazida (ili bilo koja kombinacija s hidroklorotiazidom)
Clinipharm Co. Ltd Tel: +356 21 43 74 15
Ltd Tel: +356 21 43 74 15
Week 2 (day 8-14): The patient should take 1 ml solution (10 mg) equivalent to two pump actuations per day for 7 days.
2. tjedan (8. - 14. dan): Bolesnik treba uzimati 1 ml otopine (10 mg) što odgovara dva potiska pumpice dnevno, tijekom 7 dana.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR 42 TABLETS AS INTERMEDIATE PACK / COMPONENT OF A MULTIPACK (WITHOUT BLUE BOX)
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA 42 TABLETE KAO SREDNJE PAKIRANJE/ DIO VIŠESTRUKOG PAKIRANJA (BEZ PLAVOG OKVIRA)
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAPPER LABEL ON MULTIPACKS (10 x 50 ml) WRAPPED IN FOIL (INCLUDING BLUE BOX)
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU NALJEPNICA NA VANJSKOM OMOTU VIŠESTRUKIH PAKIRANJA (10 x 50 ml) ZAMOTANIH
EU/1/12/799/010 840 film-coated tablets (20 packs of 42) EU/1/12/799/011 980 film-coated tablets (10 packs of 98) EU/1/12/799/012 1000 film-coated tablets (20 packs of 50)
EU/1/12/799/010 840 filmom obloženih tableta (20 pakiranja po 42) EU/1/12/799/011 980 filmom obloženih tableta (10 pakiranja po 98) EU/1/12/799/012 1000 filmom obloženih tableta (20 pakiranja po 50)
Take the screw cap off the bottle: The cap must be turned anticlockwise, unscrewed completely and removed (fig. 1).
Zatvarač se mora okrenuti u smjeru suprotnom od kazaljke na satu, potpuno odvrnuti i ukloniti (sl. 1).
From Week 4 on: The patient should take one 20 mg film-coated tablet per day.
Od 4. tjedna nadalje: Bolesnik treba uzimati jednu filmom obloženu tabletu od 20 mg dnevno.
Very rare (may affect up to 1 in 10,000 users): • Seizures
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba):
No genotoxicity has been observed following testing of memantine in standard assays.
Testiranjem memantina u standardnim pokusima nije primijećena genotoksičnost.
Although no causal relationship has been established, close monitoring of prothrombin time or INR is advisable for patients concomitantly treated with oral anticoagulants.
Iako uzročna povezanost nije utvrđena, preporučljivo je pažljivo praćenje protrombinskog vremena, odnosno
A pivotal monotherapy study in a population of patients suffering from moderate to severe Alzheimer's disease (mini mental state examination (MMSE) total scores at baseline of 3 - 14) included a total of 252 outpatients.
Alzheimerove bolesti (početne vrijednosti kratkog testa određivanja mentalnog statusa (MMSE; engl. mini mental state examination) bile su 3-14) uključivalo je ukupno 252 ambulantna bolesnika.
In postmarketing experience these events have been reported in patients treated with Memantine Merz.
Ovi su događaji prijavljeni u postmarketinškom razdoblju kod bolesnika liječenih Memantine Merzom.
one and a half 10 mg tablet week 4 and beyond two 10 mg tablets once a day
4. tjedan i nadalje dvije tablete od 10 mg jednom dnevno
In patients with severe renal impairment (creatinine clearance 5 - 29 ml/min) daily dose should be 10 mg per day.
Kod bolesnika s teškim oštećenjem bubrežne funkcije (klirens kreatinina 5-29 ml/min) dnevna doza bi trebala biti 10 mg dnevno.
In patients with severe renal impairment (creatinine clearance 5 - 29 ml/min) daily dose should be 10 mg (1 ml solution, equivalent to two pump actuations) per day.
Kod bolesnika s teškim oštećenjem bubrebubrežne funkcije (klirens kreatinina 5-29 ml/min) dnevna doza bi trebala biti 10 mg (1 ml otopine, što odgovara dva potiska pumpice) na dan.
Microcrystalline cellulose Croscarmellose sodium Colloidal anhydrous silica Magnesium stearate
Jezgra tablete celuloza, mikrokristalična karmelozanatrij, umrežena silicijev dioksid, koloidni, bezvodni magnezijev stearat
Week 3 (day 15-21): Take one 15 mg tablet once a day (grey-orange, oval-oblong) for 7 days.
3. tjedan (15. - 21. dan): Uzimajte jednu tabletu od 15 mg jednom dnevno (sivo-narančastu, duguljasto ovalnu) tijekom 7 dana.
How to store Memantine Merz
KAKO ČUVATI MEMANTINE MERZ
EXP {MM/YYYY}
Rok valjanosti{MM/GGGG}
Package leaflet: Information for the user Memantine Merz 20 mg film-coated tablets
Uputa o lijeku: Informacija za korisnika Memantine Merz 20 mg filmom obložene tablete memantinklorid
The patient should take one 10 mg film-coated tablet per day (pale yellow to yellow, oval shaped) for 7 days.
Bolesnik treba uzimati jednu filmom obloženu tabletu od 10 mg (blijedožutu do žutu, ovalnog oblika) dnevno tijekom 7 dana.
Adverse reactions are ranked according to system organ class, using the following convention: very common (≥1/10), common (≥1/100 to < 1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to
Nuspojave su razvrstane prema klasifikaciji organskih sustava, prema sljedećim skupinama učestalosti: vrlo često (≥1/10), često (≥1/100 i <1/10), manje često (≥1/1 000 i <1/100), rijetko (≥1/10
In patients with moderate renal impairment (creatinine clearance 30 - 49 ml/min) daily dose should be 10 mg per day.
Kod bolesnika s umjerenim oštećenjem bubrežne funkcije (klirens kreatinina 30-49 ml/min), dnevna doza bi trebala biti 10 mg na dan.
Package leaflet: Information for the user Memantine Merz 10 mg film-coated tablets
Uputa o lijeku: Informacija za korisnika Memantine Merz 10 mg filmom obložene tablete memantinklorid
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet) or if you are suffering from states of renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine), as your doctor may need to adjust the dose of your medicine.
Uzimanje hrane i pića s Memantine Merz s hranom i, pićem Ako ste nedavno promijenili, ili namjeravate značajno promijeniti svoj način prehrane (npr. s normalne prehrane na strogu vegetarijansku prehranu), ili ako bolujete od stanja renalne tubularne acidoze (RTA - izrazito povećana količina tvari koje tvore kiseline u krvi zbog poremećaja rada bubrega (slaba funkcija bubrega)) ili teških infekcija mokraćnog trakta (struktura kroz koje prolazi mokraća), trebali bi obavijestiti svog liječnika jer će Vam liječnik možda morati prilagoditi dozu lijeka.
The other ingredients are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171), iron oxide yellow and red (E 172), all in the tablet coating.
Drugi sastojci su: mikrokristalična celuloza, umrežena karmelozanatrij, koloidni bezvodni silicijev dioksid i magnezijev stearat, sve u jezgri tablete; te hipromeloza, makrogol 400, titanijev dioksid (E171) i žuti željezov oksid, žuti i crveni (E172), sve u ovojnici tablete.
Week 4 (day 22-28): Take one 20 mg tablet per day (grey-red, oval-oblong) for 7 days.
4. tjedan (22. - 28. dan): Uzimajte jednu tabletu od 20 mg dnevno (sivo-crvenu, duguljasto ovalnu) tijekom 7 dana.
• There may be a possibility of reduced serum level of hydrochlorothiazide (HCT) when memantine is co-administered with HCT or any combination with HCT.
• Pri istodobnoj primjeni memantina i hidroklorotiazida (HCT-a) ili neke od kombinacija s HCT-om, postoji mogućnost smanjenja serumske koncentracije HCT-a u serumu.
GENERAL CLASSIFICATION FOR SUPPLY 15.
NAČIN IZDAVANJA LIJEKA 15. UPUTE ZA UPORABU